Naloxone T.D.®
( Naloxone)
Classification:
CNS agent (opioid antagonist)
®É|Ìe½Z¯Â·Z¿
(½Z¯Â·Z¿
Ê¿Z»{ÃÁ³
|z»d̿³Zf¿Mɯ»Ê^ºfÌ
Indications:
For the complete or partial reversal of narcotic depression induced by
opioids also for the diagnosis of suspected acute opioid overdosage.
¥»{Y»
Ìze¾ÌÀr¼ÅÁZÅ|ÌWÂÌaÁYZ]d̻¼»ºËÔÊ^¿Z˶»Z¯½{¯ÊjÀy
ZÆ¿M|uYÌ]¥»
Mechanism of Action:
It antagonizes the opioid effects by competing for the same receptor
sites.
iYºÌ¿Z°»
¶¼É|ÌWÂÌaÁYÉZÅÃ|¿Ì³Êf]Z«½{¯Ã̿³Zf¿MªËY0ÓZ¼fuY½Z¯Â·Z¿
|À¯Ê»
Precautions:
-Use cautiously to people who are known or suspected to be physically
dependent on opioids including newborns of mothers with narcotic
dependence.
ZÅY|Å
Z]{Zf »½Y{Z»YÃ||·Âf»½Y{Y¿ĸ¼mYZÅ|ÌWÂÌaÁYÄ]{Zf »½YZ¼Ì]{{Â¥»ZÌfuY
Contraindications:
Hypersensitivity to these agents.
Side/ Adverse effects:
Nausea, Vomiting, Sweating, Tachycardia, Hypertension.
Usual Adult doses:
0.4-2 mg (Repeated doses may be required )
Dosage form:
0.4 mg / ml / Amp
References:
Drug Facts and Comparisons. 2008
¥»À»{Y»
ÁY{Ä]dÌZu-
Ê^¿ZmYÂ
½ÂyZ§ËY§Y,\¸«½Z]ËY§Y,ªË e,¡Y¨fY,ÂÆe
½ÓZ³]{¥»Y|¬»
|Z]Á{Y°eÄ]ZÌ¿dY¾°¼»¹³Ê¸Ì» /-
ÊËÁY{µZ°Y
/ mg/mlµÂb»M
© Copyright 2024 ExpyDoc
